6951 - 6975 of 8404 Results
Title
Year
- Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study2016OPENTitle: Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal studyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/npjparkd.2015.27Best OA location URL: https://www.nature.com/articles/npjparkd201527.pdfCitation Count: 70
- The IgLON Family Member Negr1 Promotes Neuronal Arborization Acting as Soluble Factor via FGFR22016OPENTitle: The IgLON Family Member Negr1 Promotes Neuronal Arborization Acting as Soluble Factor via FGFR2Journal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2015.00089Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2015.00089/pdfCitation Count: 55
-
OPENTitle: Impairment of PARK14-dependent Ca2+ signalling is a novel determinant of Parkinson’s diseaseJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/ncomms10332Best OA location URL: https://www.nature.com/articles/ncomms10332.pdfCitation Count: 92
-
RESTRICTEDTitle: Neural substrates of excessive daytime sleepiness in early drug naïve Parkinson's disease: A resting state functional MRI studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 24Issue #:Start Page: 63End Page: 68Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.01.012Citation Count: 44
-
RESTRICTEDTitle: Detection of proteolytic signatures for Parkinson's diseaseJournal Name: Future NeurologyPublisher: Informa UK LimitedVol: 11Issue #: 1Start Page: 15End Page: 32Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/fnl.16.3Citation Count: 0
-
RESTRICTEDTitle: Effect of tricyclic antidepressants on L-DOPA-induced dyskinesia and motor improvement in hemi-parkinsonian ratsJournal Name: Pharmacology Biochemistry and BehaviorPublisher: Elsevier BVVol: 142Issue #:Start Page: 64End Page: 71Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pbb.2016.01.004Citation Count: 22
-
RESTRICTEDTitle: Turning On Lights to Stop Neurodegeneration: The Potential of Near Infrared Light Therapy in Alzheimer's and Parkinson's DiseaseJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2015.00500Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2015.00500/pdfCitation Count: 127
-
RESTRICTEDTitle: The novel 5-HT1A receptor agonist, NLX-112 reduces l-DOPA-induced abnormal involuntary movements in rat: A chronic administration study with microdialysis measurementsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 105Issue #:Start Page: 651End Page: 660Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2016.01.013Citation Count: 34
-
OPENTitle: Systems-level neurophysiological state characteristics for drug evaluation in an animal model of levodopa-induced dyskinesiaJournal Name: Journal of NeurophysiologyPublisher: American Physiological SocietyVol: 115Issue #: 3Start Page: 1713End Page: 1729Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1152/jn.00868.2015Best OA location URL: https://europepmc.org/articles/pmc4809970Citation Count: 24
-
RESTRICTEDTitle: Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative DiseasesJournal Name: Annual Review of Pharmacology and ToxicologyPublisher: Annual ReviewsVol: 56Issue #: 1Start Page: 489End Page: 510Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1146/annurev-pharmtox-010715-103548Best OA location URL: https://www.annualreviews.org/doi/pdf/10.1146/annurev-pharmtox-010715-103548Citation Count: 72
-
OPENTitle: LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rateJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-015-0066-zBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-015-0066-zCitation Count: 164
-
OPENTitle: Preparation of S-glycoside surfactants and cysteine thioglycosides using minimally competent Lewis acid catalysisJournal Name: Carbohydrate ResearchPublisher: Elsevier BVVol: 422Issue #:Start Page: 1End Page: 4Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.carres.2015.12.008Best OA location URL: http://manuscript.elsevier.com/S0008621515003997/pdf/S0008621515003997.pdfCitation Count: 18
-
RESTRICTEDTitle: Tandem Mass Spectrometry Multiplex Analysis of Glucosylceramide and Galactosylceramide Isoforms in Brain Tissues at Different Stages of Parkinson DiseaseJournal Name: Analytical ChemistryPublisher: American Chemical Society (ACS)Vol: 88Issue #: 3Start Page: 1856End Page: 1863Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.analchem.5b04227Citation Count: 80
-
OPENTitle: Synthesis of a Bis-thio-acetone (BTA) Analogue of the Lysine Isopeptide Bond and its Application to Investigate the Effects of Ubiquitination and SUMOylation on α-Synuclein Aggregation and ToxicityJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 11Issue #: 4Start Page: 931End Page: 942Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschembio.5b01042Best OA location URL: https://europepmc.org/articles/pmc6300141?pdf=renderCitation Count: 31
-
RESTRICTEDTitle: Activation Mechanism of LRRK2 and Its Cellular Functions in Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2016Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1155/2016/7351985Best OA location URL: http://downloads.hindawi.com/journals/pd/2016/7351985.pdfCitation Count: 24
-
RESTRICTEDTitle: Autosomal dominant Parkinson's disease caused by SNCA duplicationsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 22Issue #:Start Page: S1End Page: S6Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.09.007Best OA location URL: https://europepmc.org/articles/pmc4820832?pdf=renderCitation Count: 151
-
OPENTitle: Bioactive Flavonoids and Catechols as Hif1 and Nrf2 Protein Stabilizers - Implications for Parkinson’s DiseaseJournal Name: Aging and diseasePublisher: Aging and DiseaseVol: 7Issue #: 6Start Page: 745End Page: 745Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.14336/ad.2016.0505Best OA location URL: http://www.aginganddisease.org/EN/article/downloadArticleFile.do?attachType=PDF&id=147551Citation Count: 23
-
RESTRICTEDTitle: Biomarkers in Parkinson's disease: Advances and strategiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 22Issue #:Start Page: S106End Page: S110Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.09.048Best OA location URL: https://europepmc.org/articles/pmc5120398?pdf=renderCitation Count: 133
-
OPENTitle: Combined Optogenetic and Chemogenetic Control of NeuronsJournal Name: Methods in Molecular BiologyPublisher: Springer New YorkVol:Issue #:Start Page: 207End Page: 225Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/978-1-4939-3512-3_14Best OA location URL: https://europepmc.org/articles/pmc5149414?pdf=renderCitation Count: 32
-
OPENTitle: Detection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood‐based biomarkersJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 3Issue #: 1Start Page: 51End Page: 62Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.dadm.2016.03.002Best OA location URL: http://www.dadm.alzdem.com/article/S235287291630015X/pdfCitation Count: 77
-
RESTRICTEDTitle: Genetic susceptibility variants in parkinsonismJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 22Issue #:Start Page: S7End Page: S11Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.09.011Best OA location URL: https://europepmc.org/articles/pmc4662622?pdf=renderCitation Count: 16
- Glutathione as a Biomarker in Parkinson’s Disease: Associations with Aging and Disease Severity2016OPENTitle: Glutathione as a Biomarker in Parkinson’s Disease: Associations with Aging and Disease SeverityJournal Name: Oxidative Medicine and Cellular LongevityPublisher: WileyVol: 2016Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2016/9409363Best OA location URL: http://downloads.hindawi.com/journals/omcl/2016/9409363.pdfCitation Count: 78
-
OPENTitle: Impact of Alzheimer's Disease, Lewy Body and Vascular Co-Pathologies on Clinical Transition to Dementia in a National Autopsy CohortJournal Name: Dementia and Geriatric Cognitive DisordersPublisher: S. Karger AGVol: 42Issue #: 1-2Start Page: 106End Page: 116Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1159/000448243Best OA location URL: https://www.karger.com/Article/Pdf/448243Citation Count: 17
-
OPENTitle: Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson’s DiseaseJournal Name: Aging and diseasePublisher: Aging and DiseaseVol: 7Issue #: 3Start Page: 220End Page: 220Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.14336/ad.2015.1110Best OA location URL: http://www.aginganddisease.org/EN/article/downloadArticleFile.do?attachType=PDF&id=147509Citation Count: 15
- Molecular tweezers for lysine and arginine – powerful inhibitors of pathologic protein aggregation2016OPENTitle: Molecular tweezers for lysine and arginine – powerful inhibitors of pathologic protein aggregationJournal Name: Chemical CommunicationsPublisher: Royal Society of Chemistry (RSC)Vol: 52Issue #: 76Start Page: 11318End Page: 11334Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1039/c6cc04640aBest OA location URL: https://pubs.rsc.org/en/content/articlepdf/2016/cc/c6cc04640aCitation Count: 123